Nasonex Nasal Spray
Developed to mitigate nasal allergic congestion to support clear breathing passages and target mucosal swelling.
- Category
- Respiratory Health
- Active ingredient
- Mometasone Furoate
- Route
- Nasal use
- Form
- Nasal Spray
- Strengths
- 18g
Prescription and consultation requirements for Nasonex Nasal Spray vary by destination and are determined by the fulfilment partner.
Nasonex Nasal Spray details
- Conditions
- Allergic Rhinitis · Nasal Polyps
- Alternative names
- mometasone furoate
- Therapeutic class
- Glucocorticoid
- Pharmacological class
- Corticosteroid Nasal Spray
- Contraindications
- hypersensitivity to mometasone
- Minor side effects
- nasal burning; sneezing; headache
- Moderate side effects
- epistaxis; throat irritation; nasal ulceration
- Serious side effects
- nasal septal perforation, requires immediate medical attention
- Dosage forms
- Nasal Spray
- Administration route
- Nasal use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Merck
- Onset Time
- 12–24 hours
- Duration
- 24 hours
- Storage instructions
- Store between 2°C and 25°C. Do not freeze.
- Drug interactions
- Ketoconazole
- Age restrictions
- Approved for children over two years and adults.
Patient summary
developed to mitigate nasal allergic congestion to support clear breathing passages and target mucosal swelling.
Mechanism of action
Inhibits multiple inflammatory cells and decreases localised cytokine output to resolve mucosal vascular oedema.
Pregnancy and breastfeeding
TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a doctor.